Your session is about to expire
← Back to Search
Validation of Handheld Ultrasound Devices in Rheumatology
N/A
Waitlist Available
Led By Gurjit Kaeley, Prof
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
No Placebo-Only Group
Summary
The goal of this clinical trial is to test the concurrent validity of the Clarius handheld ultrasound devices versus gold-standard device to detect characteristic features of healthy and rheumatic joints in adults Psoriatic Arthtritis patients (i.e. anatomical structures and vascular flow).
Eligible Conditions
- Psoriatic Arthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Intraarticular synovitis scoring
Secondary study objectives
Assessment of entheses images
Assessment of nail images
Assessment of tendon images
+1 moreOther study objectives
Adverse event
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Psoriatic arthritisExperimental Treatment1 Intervention
Age ≥18, Meets the classification for psoriatic arthritis (CASPAR) criteria, Able to provide an informed consent, Having peripheral disease phenotype of PsA, At least one tender and swollen join on the day of US
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~4090
Find a Location
Who is running the clinical trial?
Ottawa Hospital Research InstituteLead Sponsor
577 Previous Clinical Trials
3,139,918 Total Patients Enrolled
University of FloridaOTHER
1,409 Previous Clinical Trials
767,193 Total Patients Enrolled
NovartisIndustry Sponsor
1,639 Previous Clinical Trials
2,774,273 Total Patients Enrolled
3 Trials studying Psoriatic Arthritis
1,564 Patients Enrolled for Psoriatic Arthritis
University Health Network, TorontoOTHER
1,531 Previous Clinical Trials
504,292 Total Patients Enrolled
1 Trials studying Psoriatic Arthritis
Gurjit Kaeley, ProfPrincipal InvestigatorUniversity of Florida
Sibel Z Aydin, ProfPrincipal InvestigatorOttawa Hospital Research Institute
Lihi Eder, ProfPrincipal InvestigatorWomen's College Hospital